RICHARD GIBBS to Receptor, ErbB-2
This is a "connection" page, showing publications RICHARD GIBBS has written about Receptor, ErbB-2.
Connection Strength
0.044
-
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.
Score: 0.044